【04/21券商評等報告彙整】昱展新藥(6785) 今日僅1家券商發布績效評等報告，券商券商評價為看多，評等評等評價目標價為250元。報告報告標價欧意交易所官方Pro

CMoney 小編

• 2026-04-21 10:20
• 更新：2026-04-21 10:20

• 券商評等報告彙整
• 收藏

昱展新藥(6785)今日僅中國信託綜合證券發布績效評等報告，彙整評價為看多，昱展目標價為250元。新藥
預估 2026年度營收約1.59億元、今日僅家績效EPS約1.23元。發布

想知道更多股市相關資訊，為看為元欧意交易所官方Pro可點擊下方連結，多目從籌碼K線APP查詢哦！券商券商
https://www.cmoney.tw/r/2/d04n9s

CMoney 小編

CMoney團隊透過大數據分析，評等評等評價每日提供股市重大事件資訊，報告報告標價期望讓投資人更有效率找出理想的彙整投資標的。

昱展

Disclaimer: All text and images published on this site are adapted or collected from the Internet. We do not use them for any commercial purpose, and the copyright belongs to the original author. Since we cannot contact the copyright holders for some content, please contact us to delete it if it infringes or involves illegality. Please keep the original address for reprinting: http://cjkzx.com/html/99e4299858.html